MarginsXMarginsX
Home › Markets › PTIX

Protagenic Therapeutics, Inc.\new (PTIX)

PTIX is quoted over the counter, not listed on an exchange. Protagenic Therapeutics, Inc.\new files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Close · November 16, 2026
$0.4500
-2.2% on the day
1-year return
-77.8%
Market cap
$815K
Nano cap. From the Nov 16, 2026 close × 1.8M shares (10-Q cover page, Nov 6, 2026)
P/E and P/S
0.1× · No revenue line filed
On trailing twelve months to September 30, 2026 (10-Q)

Closes: Yahoo Finance daily closes, last bar 2026-11-16.

Profile

FieldValue
TickerPTIX, quoted over the counter
SEC CIK0001022899
OTC Markets tierOTCQB (price source, 2026-11-13)
SEC industry codePharmaceutical Preparations
Business addressNew York, NY
Incorporated inDE

Warning signs

Cash runway
0.8 months
$77K cash at September 30, 2026
Share count, 1 year
-6.4%
2025-11-26 to 2026-11-06 · +471.4% over 3 years
Going-concern doubt
Yes
10-Q filed November 6, 2026
Insider net buying, 12 months
$31K
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"Accordingly, these conditions raise substantial doubt about the Company's ability to continue as a going concern within one year after the date these financial statements are issued."
10-Q 2026-11-06
Cash and burn$77K cash; operating cash flow -$273K a quarter.Report 2026-09-30
Shares outstanding1,810,208 (2026-11-06); 1,934,878 a year earlier; 4,435,132 three years earlier. 3y figure adjusted for splits (1-for-14 overall).Cover page 2026-11-06
Reverse splits, 3 years1; latest 1-for-14 on 2025-05-05Source 2025-05-05
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 months1 (8-K item 3.01)8-K 2026-01-05
Delisting25-NSE filed25-NSE 2026-01-23
AuditorGreenGrowth CPAs, Irvine, California, United States; changed auditors 1 time in 24 months8-K 4.01 2025-08-22
Late filings, 12 months3 NT noticesNT 10-Q 2026-08-14
Insider trades, 12 monthsBought $31K, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
Not filed-$667K-$489K$77KNo debt tagsNeeds four quarters10-Q 2026-11-06
Q2 2026
2026-06-30
Not filed-$964K-$944K$566KNo debt tagsNeeds four quarters10-Q 2026-11-06
Q1 2026
2026-03-31
$0$5.1M$266K$1.5MNo debt tags$010-K 2026-08-14
Q4 2025
2025-12-31
$0$2.2M$74K$2.2M$4.0M$010-Q 2026-03-09
Q3 2025
2025-09-30
$0-$869K-$1.4M$2.7M$4.0M$010-Q 2025-11-26
Q2 2025
2025-06-30
$0-$5.1M-$1.8M$4.1M$3.2M$010-QT 2025-09-10
Q1 2025
2025-03-31
$0-$1.4M-$1.1M$15K$2.4M$010-Q 2025-05-13
Q4 2024
2024-12-31
$0-$850K-$820K$80KNo debt tags$010-K 2025-03-31

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52025-10-24
Latest annual report10-K2026-08-14
Latest quarterly / interim10-Q2026-11-06
Latest current report8-K2026-11-06
Latest proxyDEF 14A2025-12-05

Source: SEC EDGAR submissions feed, 707 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier